Powerball: See the winning numbers in Wednesday's $643 million drawing
Here are Wednesday's winning lottery numbers:
31-59-62-65-68, Powerball: 05, Power Play: 2X
Double Play Winning Numbers
16-17-23-46-52, Powerball: 03
The estimated Powerball jackpot is $643 million. The lump sum payment before taxes would be about $290.6 million.
The Double Play is a feature that gives players in select locations another chance to match their Powerball numbers in a separate drawing. The Double Play drawing is held following the regular drawing and has a top cash prize of $10 million.
Powerball is held in 45 states, the District of Columbia, the U.S. Virgin Islands and Puerto Rico. The Double Play add-on feature is available for purchase in 13 lottery jurisdictions, including Pennsylvania and Michigan.
A $2 ticket gives you a one in 292.2 million chance at joining the hall of Powerball jackpot champions.
The drawings are held at 10:59 p.m. Eastern, Mondays, Wednesdays and Saturdays. The deadline to purchase tickets is 9:45 p.m.
Read the original article on MassLive.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
How Trump became his own Fed chair nominee's loudest critic
The market is watching for signs from Federal Reserve Chair Jerome Powell's Friday speech about whether the central bank will lower interest rates at its September meeting. President Trump has been vocal in his opinion that the Fed is overdue to cut rates and in his criticism of Powell himself. Christopher Leonard, author of "The Lords of Easy Money: How the Federal Reserve Broke the American Economy," recaps how the president went from nominating Powell for Fed chair to name-calling on social media. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend. Related videos iFAST's Share Price Plunged 8.5% Recently: Should Investors Get Worried? Better Buy: Mapletree Logistics Trust Vs Mapletree Pan Asia Commercial Trust UPDATE 1-Singapore's Temasek mulls three-way split, Bloomberg News reports 2 Clear Signs of a Great Dividend Stock in Singapore Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
AAHI Partners with Quratis to Strengthen Global Vaccine Manufacturing and Accelerate Access to Lifesaving Vaccines
SEATTLE, August 21, 2025--(BUSINESS WIRE)--Access to Advanced Health Institute (AAHI), a global leader in translating high-impact science into scalable, field-ready vaccine solutions, today announced an exciting new partnership with Quratis, a premier biotechnology company and advanced Contract Development and Manufacturing Organization (CDMO). This collaboration marks a pivotal step forward in breaking through barriers in global health equity around the world. Under this strategic alliance, Quratis has been selected as AAHI's preferred manufacturer for high-quality pre-clinical and clinical vaccine supplies, with the capacity to expand into commercial-scale production for global markets. This collaboration will accelerate the development of AAHI's innovative vaccine candidates targeting deadly diseases such as tuberculosis, and of vaccines that rely on AAHI's vaccine adjuvants to provide protection against malaria, HIV, and other global health threats. Quratis brings a world-class GMP-certified bioplant and cutting-edge CDMO expertise in biopharmaceutical raw material development, process optimization, and finished pharmaceutical manufacturing. By designating Quratis as preferred partner, AAHI strengthens both its scientific capabilities and access to scalable, cost-effective production of its groundbreaking vaccine formulations—including dry vaccines that eliminate cold chain dependencies and needle-free delivery systems for superior respiratory protection. The partnership ensures a seamless supply chain platform, enabling swift clinical development and broader deployment to the world's most vulnerable populations. "Partnering with Quratis is a very important step in AAHI's strategy to advance practical, life-saving vaccines, that can be deployed at scale where they're needed most," said Keeley Foley, CEO of AAHI. "Quartis' innovative cutting edge, safe, world-class CDMO capabilities makes it possible for AAHI to deliver on our mission – and helps ensure our efforts to combat infectious diseases and foster health autonomy worldwide. Together, we're not just manufacturing vaccines—we're delivering an important mission to revolutionize global health." Quratis, renowned for its global innovation in healthcare, brings unparalleled expertise in vaccine development and manufacturing to the table. With a track record of success in TB and COVID-19 vaccines like QTP101 and QTP104, Quratis' advanced processes will enhance AAHI's pipeline, ensuring high-quality, efficient production from pre-clinical stages through clinical trials. "We are honored and thrilled to join forces with AAHI, a pioneer in immune-enhancing technologies and sustainable vaccine solutions," said Soung Joon Kim, CEO of Quratis. "This partnership aligns perfectly with our vision of making people happy and healthy through borderless healthcare innovations. By supporting AAHI's pipeline, we expect to create value not only for global health, but also for our shareholders through long-term growth opportunities." The partnership builds on existing collaborations, including the co-development of the ID93+GLA-SE tuberculosis vaccine candidate (QTP101), and underscores a shared commitment to strengthening international vaccine supply chains, advancing equitable access, and fostering worldwide manufacturing capacity for sustainable program deployment. For more information about this partnership or to explore collaboration opportunities, and order pre clinical materials please contact info@ About Access to Advanced Health Institute (AAHI) Access to Advanced Health Institute (AAHI) is a global leader in developing practical, cost-effective vaccines to combat deadly diseases such as tuberculosis, malaria, and HIV. With a mission to translate high-impact science into scalable, field-ready solutions, AAHI breaks through barriers in global health by creating innovative vaccine formulations, building worldwide manufacturing capacity, and fostering partnerships to ensure sustainable, equitable health outcomes. For more information, visit or contact us at info@ About Quratis Quratis Inc. is a leading biopharmaceutical company specializing in innovative vaccine development and advanced biologics manufacturing. With a state-of-the-art GMP facility and strong global partnerships, Quratis is at the forefront of developing next-generation vaccines against infectious diseases, including tuberculosis, COVID-19, schistosomiasis, and neglected tropical diseases. In addition to its core vaccine pipeline, Quratis offers superior CDMO capabilities, including expertise in mRNA–LNP drug delivery platforms that provide seamless bench-to-field support from research through commercial production. By combining cutting-edge R&D with scalable manufacturing, Quratis is committed to delivering high-quality, accessible, and life-saving solutions to patients worldwide. For more information, visit View source version on Contacts Casey Felipeinfo@ Sign in to access your portfolio
Yahoo
20 minutes ago
- Yahoo
082225_wdt-fox-cannabis
Aug. 21—WATERTOWN — Four years after opting out of allowing state-regulated cannabis dispensaries from operating within the city limits, the Watertown City Council may repeal the ban next month. A hearing has been scheduled for 7:15 p.m. Sept. 2 at City Hall, 245 Washington St. Council members are expected to vote on the issue after hearing from the public. The Marijuana Regulation and Taxation Act, signed into law by Gov. Andrew M. Cuomo in March 2021, allowed cities, towns and villages to opt out of allowing retail dispensaries. That decision also meant the municipalities were not eligible for tax revenue generated by marijuana sales. After debate and the failure to generate enough signatures for a referendum to force the allowance in 2021, Watertown has sat out from collecting any tax revenue from one of the state's fastest-growing industries. The state allows municipalities to retain 3% of a total 13% excise tax on the retail sale of marijuana. According to the 2024 Annual Report of the Office of Cannabis Management, more than 5,250 licenses, permits and registrations were approved from 2023 to the end of the state's fiscal year of 2024. As of November of that year, $757.8 million had been generated statewide by retail sales of cannabis. Of that figure, $80.2 million was collected in taxes, fees and fines. Four cannabis retail shops now operate in Jefferson County — in Theresa, Pamelia, West Carthage and Evans Mills. Cannabis Depot opened in May 2024 just over the city line on Route 12. There is a constant stream of customers at the shop that is providing tax revenue to Pamelia. Councilwoman Lisa A. Ruggiero said allowing dispensaries in Watertown could generate needed revenue for the city. City Manager Eric F. Wagenaar told the council that allowing marijuana dispensaries could bring in approximately $100,000 annually, though Ruggiero believes that figure could be higher. Councilman Cliff G. Olney III said he supports repealing the local law. Ruggiero and Councilman Robert O. Kimball said they are leaning toward voting in favor of repealing the local law. Councilman Benjamin P. Shoen and Mayor Sarah V.C. Pierce are awaiting public feedback before committing. Pierce said she was "open to the idea" and looks forward to hearing from the public. Ruggiero noted that many smoke shops are currently operating in the city, and it remains unclear whether they are selling marijuana illegally. State-sanctioned dispensaries, she said, must adhere to regulations. At last count, there were as many as 30 smoke shops operating in Watertown. "They're everywhere," Ruggiero said. "They're on every corner." The state has closed illegal shops in Watertown and statewide. In 2024, roughly 1,300 inspections were carried out, and 450 businesses were padlocked, the OCM report states. Through that effort, 16,900 pounds of unlicensed cannabis products were seized — a street value of $68.5 million. Shoen said it may be better to permit dispensaries for the safety of the cannabis users. He said some of those people have expressed support for the shops. Ruggiero, who initiated the review of the issue, said the city contacted local law enforcement to assess whether existing dispensaries in the county are causing public safety issues. West Carthage Police Officer Dave Pustizzi said there have been "no issues" with the dispensary there, while Jefferson County Sheriff Peter R. Barnett noted deputies responded a couple of times to the Pamelia dispensary but reported no problems at the others. Barnett added that the dispensaries are professionally operated and attract a diverse clientele. While he's leaning to vote yes, Kimball still has concerns about studies that show marijuana disorders are on the rise. He's also concerned about cannabis-related hospital visits by children, whose parents don't take precautions to make sure that their children don't get into gummies or other pot products. Anita Seefried-Brown, project director for the Alliance for Better Communities, is worried that having a pot shop in Watertown will send a bad message to the city's youth, especially since there are already so many smoke shops operated in the city. A survey of school-aged children found that 10% of seventh graders have tried marijuana, she said. According to the law, state law prohibits the city from restricting the number of dispensaries. These businesses must follow zoning laws and are only allowed in commercial districts. The state law also permits the creation of designated places for marijuana consumption, but regulations on such establishments are still under development, so they are not yet permitted. "While this proposal supports permitting the sale of retail cannabis within the City, it continues the City's opt-out of licensing and establishing on-site cannabis consumption establishments," according to a memo to City Council from Wagenaar. "This position is based on the fact that New York State's rules and regulations governing on-site consumption, whether at dispensaries or other venues, have not yet been finalized," Wagenaar stated in the memo. "Maintaining the opt-out status for on-site consumption ensures the City can fully evaluate the State's final guidance before considering any changes." Solve the daily Crossword
